# LLM Judge Evaluation: tier1_008

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 2/2
- **Tool Use**: 2/2
- **Total**: 6/6

### Reasoning:
Completion:
- The trace shows the redox workflow was submitted for melatonin (SMILES looked up), progressed from RUNNING to COMPLETED_OK, and the agent then retrieved the results. The final answer contains a numerical oxidation potential and an interpretation. Therefore, completion criteria are satisfied.

Correctness:
- I validated the reported oxidation potential (0.832 V vs SCE, MeCN) against experimental literature. Multiple aqueous CV studies place melatonin’s anodic peak at ~0.79 V vs Ag/AgCl; converting Ag/AgCl(sat’d KCl) to SCE at 25 °C adds ~0.044 V, giving ~0.835 V vs SCE—essentially identical to the agent’s 0.832 V (absolute error ~0.003 V, ~0.36%). I also found an independent dataset listing melatonin at 0.730 V vs Ag/AgCl under aqueous conditions; this converts to ~0.774 V vs SCE (difference from 0.832 V ≈ 0.058 V, ~7.5%), still reasonable given differing media and conditions. These cross-checks support correctness. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9079856/?utm_source=openai))

Tool Use:
- Tools were used appropriately and in a logical sequence: molecule_lookup → submit_redox_potential_workflow (oxidation, MeCN, rapid) → periodic status checks → retrieve_workflow. All tool calls returned success; parameters were sensible (neutral melatonin, singlet multiplicity). No superfluous tools or failures observed.

### Feedback:
- Strong execution: correct structure lookup, sensible workflow setup (oxidation in MeCN), proper polling, and successful retrieval; clear final number and interpretation.
- To improve auditability, explicitly quote the numerical result from the retrieved workflow object (e.g., include the field name/value) and report the computational method level (“rapid” often implies semi-empirical/continuum; specify the level/theory if available).
- Note electrode/solvent/reference explicitly in the final statement and, when interpreting biological stability, mention that physiological electrochemistry is aqueous and pH-dependent; consider adding an aqueous-pH estimate or conversion for direct biological relevance.
- Literature validation: 1) Agent’s computed value:
- 0.832 V vs SCE in acetonitrile (oxidation potential of melatonin).

2) Literature value(s) and sources:
- 0.79 V vs Ag/AgCl (aqueous BR buffer, pH 3) for melatonin; converting to SCE by adding ~0.044 V (SCE − Ag/AgCl at 25 °C) gives ~0.835 V vs SCE. Sources:
  • Electroanalytical study reporting melatonin peak at ~0.79 V vs Ag/AgCl. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9079856/?utm_source=openai))
  • Reference electrode offsets (Ag/AgCl(sat’d KCl) = +0.197 V vs SHE; SCE = +0.241 V vs SHE at 25 °C → Δ ≈ +0.044 V). ([mcauleygroup.net](https://mcauleygroup.net/ref_pots?utm_source=openai))

- Cross-check: 0.730 V vs Ag/AgCl for melatonin measured by CV (aqueous, 0.2 M LiClO4), which converts to ~0.774 V vs SCE. ([patents.justia.com](https://patents.justia.com/patent/10653779))

3) Absolute error (using primary literature-converted value):
- |0.832 − 0.835| = 0.003 V

4) Percent error:
- 0.003 / 0.835 × 100% ≈ 0.36%

5) Score justification:
- The computed value matches the literature-converted value within ~0.003 V. Even considering solvent differences (MeCN vs aqueous) and electrode/material effects, this agreement is excellent. Hence Correctness = 2/2.

Notes:
- Reference conversions: SCE − Ag/AgCl(sat’d KCl) ≈ +0.044 V at 25 °C. ([mcauleygroup.net](https://mcauleygroup.net/ref_pots?utm_source=openai))
- Literature measurements are in aqueous media; oxidation potentials for indolic compounds can shift in MeCN. Despite this, the agreement remains strong.

### Web Search Citations:
1. [A nano-magnetic electrochemical sensor for the determination of mood disorder related substances - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9079856/?utm_source=openai)
2. [A nano-magnetic electrochemical sensor for the determination of mood disorder related substances - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9079856/?utm_source=openai)
3. [Tabulated Standard Reference Electrode Potentials](https://mcauleygroup.net/ref_pots?utm_source=openai)
4. [U.S. Patent for Formulations with reduced oxidation Patent (Patent #  10,653,779 issued May 19, 2020) - Justia Patents Search](https://patents.justia.com/patent/10653779)
5. [Tabulated Standard Reference Electrode Potentials](https://mcauleygroup.net/ref_pots?utm_source=openai)

### Execution:
- **Tools**: submit_redox_potential_workflow, molecule_lookup, workflow_get_status, retrieve_workflow
- **Time**: 8.0 min

---
*Evaluated with openai/gpt-5*
